statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Are Bullish on Top Healthcare Picks

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CalciMedica (CALC Research Report) and Y-Mabs Therapeutics...

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora in Severe Acute Kidney Injury (AKI)

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora in Severe Acute Kidney Injury (AKI) CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora in...

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences PR Newswire LA JOLLA...

CalciMedica Set to Join Russell Microcap Index

CalciMedica Set to Join Russell Microcap Index CalciMedica Set to Join Russell Microcap Index PR Newswire LA JOLLA, Calif., July 1, 2024 LA JOLLA, Calif., July 1, 2024 /PRNewswire/ -- CalciMedica...

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP)

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute...

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP)

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) CalciMedica to Host Conference Call to Review Topline Data from Phase 2b...

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates...

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 PR Newswire LA JOLLA, Calif., May 7, 2024...

Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CalciMedica (CALC Research Report), Apollomics (AP...

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates PR Newswire LA JOLLA, Calif...

CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.

Volume	1,922.00
52-Wk High	$8.38
52-Wk Low	$1.75

CALC CalciMedica Inc

About

Feed

News

Fundamentals